GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wearable Health Solutions WHSI · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2023

Revenue

$745,093

FY2014FY2023

Net income

−$2.4m

FY2014FY2023

Free cash flow

−$1.3m

FY2014FY2023

Shareholders' equity

−$3.6m

FY2014FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$745,093$1.0m$1.4m$1.2m$1.0m$976,003$850,638$1.3m$1.1m$1.2m
Research and development$49,680$390,828$149,000——$2,125$2,125$32,400$32,400$25,000
Operating income−$2.3m−$13.0m−$3.2m−$495,650−$41,986−$235,600−$3.9m−$587,135−$512,376−$1.1m
Net income−$2.4m−$13.1m−$3.3m−$453,820−$132,316−$279,241−$3.7m−$780,363$826,699$225,041
Diluted earnings per share-0.00-0.01-0.00-0.00-0.00-0.00-0.05-0.060.110.04

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$223,173$339,060$907,806$644,309$292,426$230,014$415,719$570,839$274,653$1.2m
Cash and short-term investments$136,151$70,505$847,430−$101,309$59,580$4,517$30,632$106,411$1,335$7,673
Total liabilities$3.8m$2.4m$4.3m$2.9m$1.9m$1.7m$1.7m$1.7m$1.1m$3.2m
Debt$2.8m$1.9m$2.7m$1.7m$1.2m$1.1m$1.1m$857,596$474,294$30,908
Shareholders' equity−$3.6m−$2.1m−$3.4m−$2.3m−$1.6m−$1.5m−$1.2m−$1.1m−$808,693−$2.0m
Shares outstanding2,335m1,532m1,036m756m97m60m72m12m7m6m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$1.3m−$3.1m−$1.2m−$517,761−$2,833−$174,519−$130,652−$774,022−$466,372−$25,684
Capital spending−$9,442−$50,000−$50,000−$50,000−$50,000——−$53,625——
Free cash flow−$1.3m−$3.2m−$1.2m−$567,761−$52,833−$174,519−$130,652−$827,647−$466,372−$25,684

Latest quarters

By quarter end

Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022
Revenue$127,250$142,412$136,849$193,745$198,039$216,460$226,289$212,982
Operating income−$71,699−$335,731−$535,047−$479,642−$519,427−$760,025−$958,578−$7.4m
Net income$125,231$18,902−$577,768−$607,139−$560,155−$737,509−$957,852−$7.4m
Diluted earnings per share0.000.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$89,580$125,315$223,173$129,915$208,798$426,154$339,060$632,321
Cash and short-term investments$410$10,658—$16,341$45,474$255,904—$569,973
Debt$2.4m$2.5m—$1.9m$1.7m$1.5m—$1.6m
Shareholders' equity−$3.1m−$3.4m−$3.6m−$2.9m−$2.5m−$2.0m−$2.1m−$1.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-13.8%-5.3%3.4%
Operating income66.7%57.6%14.1%
Net income73.9%53.6%0.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-856.4%-436.8%-304.0%-229.3%
Net margin-862.2%-441.7%-309.5%-224.6%

Valuation history

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019
Price to earnings-0.1-0.1-0.2-0.2-0.0
Price to sales0.30.70.50.1—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%-11%-69%-47%875%148%5951%139158%1693%73%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 800-to-1 reverse split · 24 Feb 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.